Donald Yacktman Latest Moves Involve SYSCO Corporation (SYY)

In its latest filing, Donald Yacktman’s Yacktman Asset Management reported slightly trimming its position in SYSCO Corporation (NYSE:SYY). The fund currently holds 32.10 million shares of the company, which are equal 5.5% of the common stock. Earlier, the fund’s stake in Sysco contained 33.07 million shares.

Donald Yacktman

SYSCO Corporation (NYSE:SYY) sells, markets and distributes food products to restaurants, healthcare and educational facilities, lodging establishments and other customers who prepare meals away from home. The company operates 193 distribution facilities serving approximately 425,000 customers.

In addition, Yacktman reported moves in several more companies from its equity portfolio.

The fund disclosed ownership of 62.37 million class A shares of Twenty-First Century Fox Inc. (NASDAQ:FOXA), which represent 6.2% of the stock. The position has been decreased from 70.75 million shares held previously. Twenty-First Century represents one of the largest holdings in Yacktman’s equity portfolio at the end of 2013.

Also, in a separate filing, the fund reported a position in Resource America Inc. (NASDAQ:REXI), representing 4.97% of the company. The fund currently owns 1.51 million shares of the company. In The Clorox Co. (NYSE:CLX), the fund disclosed ownership of 6.14 million shares. The stake amasses 4.7% of the company. Also, the fund reported a position in Apollo Education Group Inc. (NASDAQ:APOL) which amasses 6.6% of the company, and contains 7.46 million shares.

In two other filings, the fund disclosed a position in Bancorp Inc. (NASDAQ:TBBK), representing 1.4% of the company, and a 10% stake in f C.R. Bard Inc. (NYSE:BCR). The fund owns 529,745 shares of Bancorp and 7.76 million shares of C.R. Bard respectively.

Disclosure: none

Recommended Reading:

Royce & Associates Top Picks: Thor Industries Inc. (THO), Reliance Steel & Aluminum (RS) & More

Icahn Discussed: Share Buyback Proposal Unnecessary

Hedge Fund News: Bill Ackman, Carl Icahn & Ken Griffin

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!